|

Feasibility and Effectiveness of Respiratory Movement Management in Lung Cancer Receiving Stereotactic Radiotherapy Using a Novel Positional Fixation Device

RECRUITINGSponsored by Tianjin Medical University Cancer Institute and Hospital
Actively Recruiting
SponsorTianjin Medical University Cancer Institute and Hospital
Started2026-05-10
Est. completion2026-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

The purpose of this clinical trial is to understand the safety and effectiveness of abdominal pressure devices in inhibiting respiratory movement in lung cancer patients. The main question it aims to answer is: Did the abdominal pressure device reduce the respiratory movement of participants with lung cancer tumors? Participants will: Record how much they use abdominal pressure devices to suppress lung cancer tumor respiratory movement

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

Clinical diagnosis is solitary peripheral lung cancer, and after comprehensive evaluation by the participating physicians based on the patient's clinical data, it is suitable for receiving SBRT treatment;

Exclusion Criteria:

Central or super central lung cancer patients who are intolerant or unwilling to undergo respiratory suppression and chest and abdominal compression fixation

Conditions3

CancerLung CancerLung Cancer - Non Small Cell

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.